- Lobbying
- Lobbying by AstraZeneca Pharmaceuticals LP
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Stefan Bailey | 2003-2004: Legislative Assistant, Rep. Baron Hill (IN-09); 2004-2005: Press Secretary/Legislative Director, Rep. Baron Hill (IN-09); 2005-2007: Legislative Director, Rep. Nick Rahall (WV-03) |
Rich Meade | 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives |
Emily Katz | 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH |
Martin Paone | 1995-2001: Secretary for the Minority, Senate; 2001-2002: Secretary, Majority, Senate; 2002-2007: Secretary, Minority, Senate; 2007-2008: Secretary, Majority, Senate; 2015-2017: Deputy Assistant to the President for Legislative Affairs, White House |
Ann Adler | Sen Robert Byrd: CoS (2000-04); House Natural Resources Cmte: Sr Policy Advisor (2004-07), Dep CoS (2007-11); House Transportation Cmte: Dep CoS (2011-15); Interior Dept: Chief, Congressional/Legislative Affairs (2015-17); Rep Sean Casten: CoS (2019) |
Charles Black | n/a |
Karen Antebi | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Registration
Issue(s) they said they’d lobby about: Advising on issues related to healthcare and sustainability.
Q4 Report
Lobbying Issues
Agencies Lobbied
White House Office
Agriculture - Dept of (USDA)
Type of Issue
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
White House Office
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
U.S. Agency for International Development (USAID)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
White House Office
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Registration
Issue(s) they said they’d lobby about: COVID-19 vaccine and therapy development and deployment.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate